X. Long Zheng, MD, PhD?
Update this Profile
X. Long Zheng, MD, PhD, Pathologist
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

X. Long Zheng, MD, PhD

Pathologist | Blood Banking & Transfusion Medicine

3901 Rainbow Blvd Kansas City KS, 66160

About

Dr. X. Long Zheng is a clinical pathologist practicing in Kansas City, KS. Dr. Zheng specializes in coagulation and transfusion medicine. He is world renowned expert in diagnosis and management of thrombotic thrombocytopenic purpura (TTP) a rare but potentially fatal blood disorder. Dr. Zheng discovered and cloned ADMTS13, a plasma metalloprotease that cleaves von Willebrand factor. Deficiency of plasma ADAMTS13  is one of the key pathogenetic factors that causes TTP. Dr. Zheng provides oversight on Apheresis, coagulation, and blood transfusion, etc.  Dr. Zheng has published more than 140 manuscripts in peer-reviewed journals and 5 book chapters. He serves in editorial boards of several key journals in the field and in NIH study sections for Hemostasis, Thrombosis, and Blood Transfusion (HTBT). 

Education and Training

Nanchang University MD 1984

University of Vienna, Austria PhD 1994

Washington University Residence training 2002

Washington University Fellowship 2003

Board Certification

American Board of Pathology

Blood Banking/Transfusion Medicine (Pathology)

Chemical Pathology (Pathology)

Provider Details

Male Mandarin Chinese, English, German

Areas of expertise and specialization

CoagulationApheresisTTPPlatelet dysfunction

Faculty Titles & Positions

  • Professor and Chair University of Kansas 2020 - Present
  • Advisory Board Member The Blood Project 2023 - Present
  • Associate Editor Journal of Clinical Translational Pathology 2022 - Present
  • Co-chair ISTH SSC VWF subcommittee 2020 - Present
  • Advisory Board International Society of Thrombosis and Haemostasis (ISTH). 2020 - Present
  • Advisory Board Member Chinese Journal of Thrombosis and Haemostasis 2021 - Present
  • Associate Editor Journal of Clinical Medicine 2020 - Present
  • Associate Editor, Arch. Pathology & Laboratory Medicine. 2023 - Present
  • Associate Editor Annals of Blood 2020 - Present
  • Advisory Board Chinese Journal of Thrombosis and Haemostasis (CJTH). 2020 - Present
  • HTBT Study section member NIH/NHLBI-Hemostasis, Thrombosis, Blood Cells and Transfusion, Bethesda, Maryland. 2018 - Present
  • Board Member of Executive Council Academy of Clinical Laboratory Physicians and Scientists 2018 - Present
  • Chair ISTH-TTP guideline development panel. 2018 - 2020
  • Director of Coagulation Laboratory, Department of Pathology the University of Alabama at Birmingham, Birmingham, AL 2017 - 2020
  • Vice Chair and Chair of Scientific Committee for Hemostasis American Society of Hematology, Washington D.C. 2014 - 2015
  • Associate Editor J. Thrombosis Haemostasis. 2014 - 2021
  • Associate Professor (tenured) Department of Pathology & Laboratory Medicine, Children’s 2011 - 2015
  • Assistant Professor (tenure-track) Department of Pathology & Laboratory Medicine, Children’s Hospital of Philadelphia and The University of Pennsylvania, Philadelphia, PA. Member of Graduate Program, Cell Biology and Physiology, The University of Pennsylvania, Philadelphia, PA. 2003 - 2010
  • Postdoctoral Research Fellow Howard Hughes Medical Institute and Division of Hematology, Washington University in St. Louis, MO. 1995 - 1999
  • Russell J. Eilers MD Endowed Professor The University of Kansas Medical Center -
  • Department Chair of Pathology and Laboratory Medicine The University of Kansas Medical Center -
  • tenured Professor of Pathology and Division Director of Laboratory Medicine University of Alabama -

Awards

  • Outstanding pathologists award 2024 Chinese association of clinical pathologists 
  • Gift-of-Life Award 2014 ReeWynn TTP foundation, New Jersey 
  • Karl Link New Investigator Award in Thrombosis 2012 ATVB Meeting, Chicago 
  • Established Investigator Award 2009 American Heart Association, National 
  • Bayer Hemophilia Award 2008 Bayer Healthcare 
  • Paul E. Strandjord Young Investigator Award 2002 Academy of Clinical Laboratory Physicians and Scientists 

Professional Memberships

  • American Association of Blood Banks  
  • American Society of Hematology  
  • Academy of laboratory physicians and scientists  
  • American society of Apheresis  
  • International society of thrombosis and haemostasis  
  • Chinese association of pathologists  
  • Association for Academic Pathology  
  • Association for the Advancement of Blood & Biotherapies  
  • Academy of Clinical Laboratory Physicians and Scientists  
  • American Society for Apheresis  
  • Chinese American Pathologists Association  

Fellowships

  • Washington University in St. Louis Hemostasis & Transfusion Medicine   2003
  • Washington University, St. Louis, MO. Transfusion Medicine/Hemostasis  2003

Treatments

  • TTP and HUS

Fellowships

  • Clinical Fellowship, Transfusion Medicine and Hemostasis, Washington University

What do you attribute your success to?

  • Dr. Zheng has spent the last 20 years on his research regarding blood disease. He is motivated and doesn\'t take no for an answer and knew his work would be fundamental in curing lifelong disease. He fights for our health.

Areas of research

Dr. Zheng's research focuses on pathogenesis and novel therapies for thrombotic thrombocytopenic purpura (TTP). 

X. Long Zheng, MD, PhD's Practice location

University of Kansas Medical Center

3901 Rainbow Blvd -
Kansas City, KS 66160
Get Direction
New patients: 913-588-7071
https://www.kumc.edu/xzheng2.html

X. Long Zheng, MD, PhD's reviews

(0)
Write Review

Media Releases

Making Strides in the Field of Pathology and Laboratory Medicine at The University of Kansas Medical Center

Dr. X. Long Zheng, currently holds the prestigious position of Russell J. Eilers MD Endowed Professor and Department Chair of Pathology and Laboratory Medicine at The University of Kansas Medical Center in Kansas City, Kansas. With an illustrious academic background and a wealth of experience in research and academia, Dr. Zheng is recognized as a leading expert in his field.

Having obtained his Medical Degree from Nanchang University, China, and his PhD from the University of Vienna, Austria, Dr. Zheng continued to expand his expertise through a residency in pathology and fellowship in transfusion medicine and hemostasis at Washington University in St. Louis, Missouri. His career trajectory saw him achieve tenured Associate Professor status at the University of Pennsylvania before being recruited to the University of Alabama at Birmingham, where he held the position of a tenured Professor of Pathology and Division Director of Laboratory Medicine.

As the principal investigator funded by the National Heart, Lung, and Blood Institute (NHLBI), Dr. Zheng’s research primarily focuses on understanding the pathogenesis of thrombotic thrombocytopenic purpura (TTP), a critical blood disorder with potentially fatal consequences. He and his colleagues have published their groundbreaking work in over 140 manuscripts in highly reputable journals and six highly sought-after book chapters such as Williams Hematology, Clinical Hematology, and Principles of Critical Care.

Dr. Zheng’s influence extends beyond his research endeavors, as he actively participates in patient care and contributes to the academic community through his roles as a standing member of the Hemostasis, Thrombosis, and Blood Transfusion (HTBT) study section at National Institute of Health (NIH), and as an associate /section editor for esteemed journals such as Archives of Pathology and Laboratory Medicine, Annals of Blood, Journal of Clinical Medicine, and Genomics, etc. His dedication to education and mentorship is evident in his guidance of numerous medical and graduate students, residents, postdoctoral fellows, junior faculty, and physician scientists.

A member of several prominent professional organizations, including the Association for Academic Pathology, the Association for the Advancement of Blood & Biotherapies, the American Society of Hematology, the Academy of Clinical Laboratory Physicians and Scientists, the American Society for Apheresis, the International Society on Thrombosis and Haemostasis, and the Chinese American Pathologists Association, Dr. Zheng’s contributions to the field have been widely recognized.

Beyond his professional accomplishments, he enjoys leisure activities such as fishing, traveling, and sightseeing, with Austria, Italy, and Switzerland holding the special places in his heart as the favorite destinations.

Recommended Articles

  • What is Epilepsy?

    Epilepsy is a neurological disorder with abnormal electrical activity in the brain, which results in repeated seizures or fits. It is a very common condition and affects millions of people in the country. Although the condition may start at any age, it is usually found to start in childhood, in most...

  • Alzheimer's Cases Expected to Quadruple by 2050

    Alzheimer’s disease is among the conditions with the most surprising projections for the next 50 years as the numbers of diagnoses are expected to quadruple. But, why?  Alzheimer’s disease is a condition that modifies a patient's lifestyle entirely. Although a cure for this neurodegenerative...

  • Does Sepsis Require Hospitalization?

    Sometimes the human body may respond to infections or injuries in an unusual manner. Sepsis is one such condition. It is a deadly disease and can become life threatening if timely treatment is not provided. While infections in the kidney, pneumonia or a persisting pain during urination are specific...

  • Cryotherapy and Weight Loss

    Cryotherapy is a technology that has been in use for decades, but its use for weight loss is just a happy accident. The idea was invented by Japan in 1978 to help reduce inflammation. This technology has become a commonplace in Europe and the US especially among athletes as it helps in the repair of...

  • What is Ondansetron Used For?

    IntroductionOndansetron helps in blocking the actions of the various chemicals (one of which being serotonin) in the body, which mostly lead to triggering of vomiting and nausea. Hence, we can say that Ondansetron is used for preventing the instances of nausea and vomiting which could have been...

  • How Quercetin Works: Health Benefits of Quercetin

    Quercetin is a flavonoid antioxidant found in plant foods. It is found in leafy vegetables, tomatoes, broccoli, and berries. Quercetin is actually a plant pigment. In the human diet, quercetin is one of the most abundant antioxidants. It destroys free radicals, and thus, fights against aging and...

Nearby Providers

Nearest Hospitals

UNIVERSITY OF KANSAS HOSPITALl

3901 RAINBOW BLVD KANSAS CITY KS 66103

3967-3985 US-169, Kansas City, KS 66103, USA
Head east toward W 39th Ave
0.2 mi
Turn right onto W 39th Ave
171 ft
Turn right onto Cambridge St
440 ft
Turn rightDestination will be on the right
144 ft
4000 Cambridge St, Kansas City, KS 66103, USA

ST LUKES HOSPITAL OF KANSAS CITYl

4401 WORNALL ROAD KANSAS CITY MO 64111

3967-3985 US-169, Kansas City, KS 66103, USA
Head east toward W 39th Ave
0.2 mi
Turn right onto W 39th AvePass by Starbucks (on the right in 0.2 mi)Entering Missouri
0.6 mi
Turn right onto Clark Ave
0.3 mi
Turn right onto Summit St/SW Trafficway
0.2 mi
Continue onto Belleview Ave
0.2 mi
Turn left onto W 44th St
0.3 mi
Turn right onto Broadway Blvd
331 ft
Turn leftDestination will be on the right
266 ft
4400 Wornall Rd, Kansas City, MO 64111, USA

CHILDRENS MERCY HOSPITALl

2401 GILLHAM ROAD KANSAS CITY MO 64108

3967-3985 US-169, Kansas City, KS 66103, USA
Head east toward W 39th Ave
0.2 mi
Turn right onto W 39th AvePass by Starbucks (on the right in 0.2 mi)Entering Missouri
0.7 mi
Turn left onto Summit St/SW Trafficway
1.0 mi
Turn right onto W 31st St
1.0 mi
Turn left onto Holmes St
0.9 mi
Turn left onto E 24th St
289 ft
600 E 24th St, Kansas City, MO 64108, USA